Results from the 2nd Scientific Workshop of the ECCO (I): Impact of mucosal healing on the course of inflammatory bowel disease
- 1 October 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Crohn's and Colitis
- Vol. 5 (5) , 477-483
Abstract
Over the past years, mucosal healing has emerged as a major therapeutic goal in clinical trials in inflammatory bowel diseases. Accumulating evidence indicates that mucosal healing may change the natural course of the disease by decreasing the need for surgery and reducing hospitalization rates in both ulcerative colitis and Crohn's disease. Mucosal healing may also prevent the development of long-term disease complications, such as bowel damage in Crohn's disease and colorectal cancer in ulcerative colitis. Histologic healing may be the ultimate therapeutic goal in ulcerative colitis, whereas its impact on the course of Crohn's disease is unknown. Complete mucosal healing may be required before considering drug withdrawal. Targeting early Crohn's disease is more effective than approaches aimed at healing mucosa in longstanding disease. Several questions remain to be answered: should mucosal healing be systematically used in clinical practice? Should we optimize therapies to achieve mucosal healing? What is the degree of intestinal healing that is required to change the disease course? Large prospective studies addressing these issues are needed.Keywords
This publication has 34 references indexed in Scilit:
- Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative ColitisGastroenterology, 2011
- Mucosal healing in patients with ulcerative colitis during a course of selective leukocytapheresis therapy: A prospective cohort studyInflammatory Bowel Diseases, 2010
- Are Colonoscopy and Bowel Ultrasound Useful for Assessing Response to Short-Term Therapy and Predicting Disease Outcome of Moderate-to-Severe Forms of Ulcerative Colitis?: A Prospective StudyAmerican Journal of Gastroenterology, 2010
- Mucosal Healing Predicts Sustained Clinical Remission in Patients With Early-Stage Crohn's DiseaseGastroenterology, 2010
- Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohnʼs diseaseInflammatory Bowel Diseases, 2009
- The Management of Paediatric Crohn's Disease: Addressing Unmet NeedsThe Open Pediatric Medicine Journal, 2008
- Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trialThe Lancet, 2008
- Short- and long-term therapeutic efficacy of nutritional therapy and corticosteroids in paediatric Crohn's diseaseDigestive and Liver Disease, 2006
- Infliximab for Induction and Maintenance Therapy for Ulcerative ColitisNew England Journal of Medicine, 2005
- Serial rectal biopsy in ulcerative colitis during the course of a controlled therapeutic trial of various dietsDigestive Diseases and Sciences, 1966